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Background
Methadone is an effective analgesic and it is widely used to
suppress withdrawal symptoms from other opiates. Its
consumption is usually associated with concomitant drug
use in heroin addicts, and this combination is a possible
risk factor for lethal outcome. The aim of this study was
to analyze characteristics of methadone-related deaths
(MRDs), and to evaluate the concomitant use of the drugs
that can contribute to methadone toxicity.
Methods
To investigate MRDs, a 10-year retrospective study was
carried out (2001–2010) at the Institute of Forensic Medi-
cine in Novi Sad, Clinical Centre of Vojvodina, Serbia.
These data included age and sex of subjects, and drugs
detected in post-mortem samples of blood and urine. Toxi-
cological screening and quantification of drugs were
carried out in blood and urine using gas chromatography-
mass spectrometry. Methadone concentration in blood was
defined to be lower than 200 µg/L, 200–1000 µg/l, or
higher than 1000 µg/L.
Results
A total number of 40 MRDs was identified (19.1% of all
deaths associated with fatal opiate-related poisoning). The
median age of victims at the time of death was 31, whereas
the majority of them (80%) were male. The concentration
of methadone in blood and urine samples was quantified in
11 cases and in 9 of them it was lower than 200 µg/L (mean
concentration 79.5 µg/L). In one case it was 245 µg/L,
whereas in the other one methadone was detected only
in urine in concentration of 1209 µg/L. In 7 cases only
methadone was found (17.5 % of MRDs); 47.5% of MRDs
was associated with other drugs – the average number of
associated drugs was 3.5, while in blood samples of 35% of
MRDs other illicit drugs were identified. The most frequent
concomitants were one or more benzodiazepines (67.5% of
MRDs), followed by antipsychotics (15%), tramadol (15%)
and antidepressants (12.5%). The most commonly identified
benzodiazepine was diazepam.
Conclusions
In MRDs a low methadone level combined with other
drugs was most frequently noted. The mechanism of
death cannot be attributed to particular pathway. The
most detected concomitants were well-known inhibitors,
inducers or metabolic substrates of CYP3A4 and
CYP2D6 involved in metabolism of methadone. More-
over, they can increase the risk of torsades de pointes
and of respiratory depressant effects of methadone.
Further studies could clarify the possible mechanism of
death where methadone is used in combination with
benzodiazepines in order to prevent MRDs.
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